{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:06:15Z","timestamp":1790885175972,"version":"4.1.0"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018525","name":"Key Research and Development Program of Sichuan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018525","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Current diagnostic criteria for cancer cachexia are inconsistent, and arguments still exist about the impact of cachexia on the survival of patients with colorectal cancer. In this study, we aim to investigate the prognostic value of a novel cachexia indicator, the cachexia index (CXI), in patients with colorectal cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The CXI was calculated as skeletal muscle index (SMI) \u00d7 serum albumin\/neutrophil-lymphocyte ratio. The cut-off value of CXI was determined by the receiver operating characteristic (ROC) curves and Youden\u2019s index. The major outcomes were major complications, overall survival (OS), and recurrence-free survival (RFS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 379 patients (234 men and 145 women) were included. The ROC curves indicated that CXI had a significantly diagnostic capacity for the detection of major complications. Based on Youden\u2019s index, there were 231 and 148 patients in the low and high CXI groups, respectively. Patients in the low CXI group had significantly older age, lower BMI, and a higher percentage of cachexia and TNM stage II+III. Besides, Patients in low CXI group were associated with a significantly higher rate of major complications, blood transfusion, and longer length of stay. Logistic regression analysis indicated that low CXI, cachexia, and coronary heart disease were independent risk factors for the major complications. Kaplan Meier survival curves indicated that patients with high CXI had a significantly more favorable OS than those with low CXI, while no significant difference was found in RFS between the two groups. Besides, there were no significant differences in OS or RFS between patients with and without cachexia. The univariate and multivariate Cox regression analysis indicated that older age, low CXI, and coronary heart disease instead of cachexia were associated with a decreased OS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>CXI was better than cachexia in predicting OS and could be a useful prognostic indicator in patients with colorectal cancer, and greater attention should be paid to patients with low CXI.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2022.984459","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T13:41:26Z","timestamp":1663940486000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":33,"title":["Prognostic value of cachexia index in patients with colorectal cancer: A retrospective study"],"prefix":"10.3389","volume":"12","author":[{"given":"Qianyi","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoding","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: An international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/jhn.12811","article-title":"Cancer cachexia: an overview of diagnostic criteria and therapeutic approaches for the accredited practicing dietitian","volume":"34","author":"van der Meij","year":"2021","journal-title":"J Hum Nutr Diet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2017.025221","article-title":"Prevalence and survival impact of pretreatment cancer-associated weight loss: A tool for guiding early palliative care","volume":"14","author":"Gannavarapu","year":"2018","journal-title":"J Oncol Pract"},{"key":"B6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.clnu.2012.05.009","article-title":"Nutritional status, cachexia and survival in patients with advanced colorectal carcinoma. different assessment criteria for nutritional status provide unequal results","volume":"32","author":"Thoresen","year":"2013","journal-title":"Clin Nutr"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01516-6","article-title":"A retrospective cohort study to investigate the incidence of cachexia during chemotherapy in patients with colorectal cancer","volume":"37","author":"Shibata","year":"2020","journal-title":"Adv Ther"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/nqaa440","article-title":"Weight stability masks changes in body composition in colorectal cancer: A retrospective cohort study","volume":"113","author":"Brown","year":"2021","journal-title":"Am J Clin Nutr"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1080\/01635581.2018.1504092","article-title":"Cancer cachexia: Identification by clinical assessment versus international consensus criteria in patients with metastatic colorectal cancer","volume":"70","author":"van der Werf","year":"2018","journal-title":"Nutr Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2016.016832","article-title":"Cancer cachexia: Beyond weight loss","volume":"12","author":"Bruggeman","year":"2016","journal-title":"J Oncol Pract"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12837","article-title":"Cachexia index as a potential biomarker for cancer cachexia and a prognostic indicator in diffuse large b-cell lymphoma","volume":"12","author":"Go","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1186\/s12885-021-08300-x","article-title":"Clinical significance of the cachexia index in patients with small cell lung cancer","volume":"21","author":"Go","year":"2021","journal-title":"BMC Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4137\/CMO.S30891","article-title":"Cachexia index in advanced non-Small-Cell lung cancer patients","volume":"9","author":"Jafri","year":"2015","journal-title":"Clin Med Insights Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-017-2958-1","article-title":"Impact of cachexia on outcomes in aggressive lymphomas","volume":"96","author":"Karmali","year":"2017","journal-title":"Ann Hematol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"7647","DOI":"10.1038\/s41598-022-11736-1","article-title":"Prognostic significance of cachexia index in patients with advanced hepatocellular carcinoma treated with systemic chemotherapy","volume":"12","author":"Goh","year":"2022","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12436","article-title":"Skeletal muscle mass loss and dose-limiting toxicities in metastatic colorectal cancer patients","volume":"10","author":"Kurk","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-020-01124-x","article-title":"Prognostic significance of sarcopenia in microsatellite-stable gastric cancer patients treated with programmed death-1 inhibitors","volume":"24","author":"Kim","year":"2021","journal-title":"Gastric Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2019.03.015","article-title":"Survival and CT defined sarcopenia in patients with intestinal failure on home parenteral support","volume":"39","author":"Oke","year":"2020","journal-title":"Clin Nutr"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13184589","article-title":"Pretreatment neutrophil-to-Lymphocyte ratio associated with tumor recurrence and survival in patients achieving a pathological complete response following neoadjuvant chemoradiotherapy for rectal cancer","volume":"13","author":"Huang","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12604","article-title":"Sarcopenia and low muscle radiodensity associate with impaired FEV1 in allogeneic haematopoietic stem cell transplant recipients","volume":"11","author":"Mishra","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13122921","article-title":"CT body composition of sarcopenia and sarcopenic obesity: Predictors of postoperative complications and survival in patients with locally advanced esophageal adenocarcinoma","volume":"13","author":"Fehrenbach","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5040","article-title":"CT-determined low skeletal muscle mass predicts worse overall survival of gastric cancer in patients with cachexia","author":"Wan","year":"2022","journal-title":"Cancer Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s10522-021-09932-z","article-title":"Sarcopenia versus cancer cachexia: The muscle wasting continuum in healthy and diseased aging","volume":"22","author":"Moreira-Pais","year":"2021","journal-title":"Biogerontology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-016-3402-0","article-title":"Weight loss versus muscle loss: Re-evaluating inclusion criteria for future cancer cachexia interventional trials","volume":"25","author":"Roeland","year":"2017","journal-title":"Support Care Cancer"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnci.2018.10.004","article-title":"Peritoneal carcinomatosis in colorectal cancer: Defining predictive factors for successful cytoreductive surgery and hyperthermic intraperitoneal chemotherapy - a pilot study","volume":"30","author":"Mahmoud","year":"2018","journal-title":"J Egyptian Natl Cancer Inst"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2019.695","article-title":"Computed tomography-determined sarcopenia is a useful imaging biomarker for predicting postoperative outcomes in elderly colorectal cancer patients","volume":"52","author":"Xie","year":"2020","journal-title":"Cancer Res Treat"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2019.10.021","article-title":"Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: A systematic review and meta-analysis","volume":"39","author":"Rinninella","year":"2020","journal-title":"Clin Nutr"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2017.07.010","article-title":"Prevalence and predictive value of pre-therapeutic sarcopenia in cancer patients: A systematic review","volume":"37","author":"Pamoukdjian","year":"2018","journal-title":"Clin Nutr"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3428","article-title":"Sarcopenia and adverse health-related outcomes: An umbrella review of meta-analyses of observational studies","volume":"9","author":"Xia","year":"2020","journal-title":"Cancer Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"B33","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1139\/H08-075","article-title":"A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care","volume":"33","author":"Mourtzakis","year":"2008","journal-title":"Appl Physiol Nutrition Metab = Physiol Appliquee Nutr Metabol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1503\/cjs.016820","article-title":"Preoperative malnutrition in patients with colorectal cancer","volume":"64","author":"Gupta","year":"2021","journal-title":"Can J Surg"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41430-019-0527-5","article-title":"Effects of enteral nutritional rich in n-3 polyunsaturated fatty acids on the nutritional status of gastrointestinal cancer patients: A systematic review and meta-analysis","volume":"74","author":"Wan","year":"2020","journal-title":"Eur J Clin Nutr"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22158002","article-title":"Inflammation-related biomarkers for the prediction of prognosis in colorectal cancer patients","volume":"22","author":"Yamamoto","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.734735","article-title":"Hypoalbuminaemia as a prognostic biomarker of first-line treatment resistance in metastatic non-small cell lung cancer","volume":"8","author":"Stares","year":"2021","journal-title":"Front Nutr"},{"key":"B38","doi-asserted-by":"publisher","first-page":"9453","DOI":"10.1038\/s41598-018-27896-y","article-title":"The dynamic change of neutrophil to lymphocyte ratio can predict clinical outcome in stage I-III colon cancer","volume":"8","author":"Li","year":"2018","journal-title":"Sci Rep"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3109165","DOI":"10.1155\/2022\/3109165","article-title":"Preoperative neutrophil-to-Lymphocyte ratio, platelet-to-Lymphocyte ratio, and CEA as the potential prognostic biomarkers for colorectal cancer","volume":"2022","author":"Ming-Sheng","year":"2022","journal-title":"Can J Gastroenterol Hepatol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12030593","article-title":"Systematic review of prognostic role of blood cell ratios in patients with gastric cancer undergoing surgery","volume":"12","author":"Schiefer","year":"2022","journal-title":"Diagnostics"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.677351","article-title":"Insulin is required to maintain albumin expression by inhibiting forkhead box O1 protein","volume":"291","author":"Chen","year":"2016","journal-title":"J Biol Chem"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/biom10101366","article-title":"Human serum albumin binds native insulin and aggregable insulin fragments and inhibits their aggregation","volume":"10","author":"Wasko","year":"2020","journal-title":"Biomolecules"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-012-0802-0","article-title":"Hypoalbuminemia","author":"Gatta","year":"2012","journal-title":"Intern Emerg Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2018-000457","article-title":"Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors","volume":"4","author":"Fuca","year":"2019","journal-title":"ESMO Open"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.774664","article-title":"High dose steroids as first-line treatment increased the risk of in-hospital infections in patients with anti-NMDAR encephalitis","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.984459\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T13:41:30Z","timestamp":1663940490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.984459\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":45,"alternative-id":["10.3389\/fonc.2022.984459"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.984459","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]},"article-number":"984459"}}